Skip to main
IQV

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 47%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings is experiencing robust growth across several segments, with notable increases in FSP, RWE, and CSMS in Q3, indicating strong year-over-year performance. The company is benefiting from improved decision-making timelines and a solid pipeline in its commercial operations, driven by recent drug launches, which has contributed to an increase in RFP flow and a significant improvement in its win rate. Furthermore, IQVIA projects a growth rate of over 4% for its R&D Services on a constant currency basis, supported by a favorable pricing environment that has enabled the company to be selective in deal-making.

Bears say

The financial analysis of IQVIA Holdings reveals several fundamental concerns contributing to a negative outlook on the stock. Firstly, the year-over-year constant currency growth has significantly declined to 3.8%, down from 6.8% in the previous quarter, indicating a weakening growth trajectory amidst challenging comparisons from the prior year. Additionally, investor apprehensions regarding potential revenue growth slowdowns in 2026 are compounded by IQV's admission that rising interest rates may exert further pressure on margins and earnings, suggesting vulnerabilities in their financial stability moving forward.

IQVIA Hlds (IQV) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 47% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 15 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $243.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $243.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.